Skip to main content

Table 4 Serum levels of IL-18 and IL-18 BP in relation to CAD subgroups

From: Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study

Disease Entities IL 18 pg/mL* p-value † IL 18 BP pg/mL* p-value †
MI + 252 (197, 327) > 0.2 23.5 (19.4, 28.5) 0.191
  - 245 (194, 320)   23.0 (19.2, 28.2)  
HT + 248 (198, 318) > 0.2 23.5 (19.5, 29.1) 0.066
  - 248 (190, 327)   22.8 (18.9, 27.2)  
T2DM + 259 (207, 364) 0.001 23.6 (19.6, 29.0) 0.163
  - 244 (192, 311)   23.0 (19.2, 28.1)  
MetS + 265 (217, 356) < 0.0001 24.1 (19.8, 29.3) 0.010
  - 243 (188, 310)   22.8 (19.1, 28.0)  
Men   256 (203, 329) < 0.0001 23.2 (19.3, 28.3) > 0.2
Women   221 (176, 290)   23.1 (18.9, 28.1)  
Current Smokers + 252 (207, 323) > 0.2 23.0 (19.2, 27.1) > 0.2
  - 247 (194, 323)   23.2 (19.3, 28.7)  
  1. * Median levels (25- and 75 percentiles)
  2. † Mann-Whitney test